Macular Degeneration Research at Bond
- Age-related Macular Degeneration, or AMD, is the leading cause of visual impairment and blindness. With an ageing population, the number of people living with the disease will increase.
- AMD is recognised as a disease highly amenable to stem cell therapy. A stem cell therapy for AMD is now considered one of the most viable applications of stem cells in the field of regenerative medicine. Transplantation of stem cell-derived retinal pigment epithelial cells is used to halt or reverse vision loss by preventing death of photoreceptors.
- Associate Professor Nigel Barnett discusses AMD and his research into age-related macular degeneration (AMD), the leading cause of blindness in the western world.
The Clem Jones Centre for Regenerative Medicine was first established in 2011 through funding from the Clem Jones Foundation. Clem Jones AO was the longest serving Lord Mayor of Brisbane and a successful business man and philanthropist. Since his death, his Estate and Foundation have funded medical research, notably in the area of macular degeneration, since Clem Jones himself suffered the disease in his later years. The Clem Jones Foundation continues to partially fund the work of the Centre, but the continuation of research is also dependent on government grant funding and donations from the public.